X. 6. Alcohol-Based Hand Sanitizers

Alcohol hand sanitizer is valuable when infection risk is real, but only briefly disturbs the skin microbiota—for everyday situations, gentle soap and water often suffice.

Convenience with Microbiota Trade-Offs

Alcohol-based hand sanitizers are effective against pathogens but can disrupt the skin microbiota and indirectly affect gut microbial balance [24].

Hand sanitisers based on alcohol have been available in clinical settings since the 1960s, but their use outside hospitals remained marginal until the late 1990s. Purell, the brand that would define the consumer market, was introduced in 1988. Adoption accelerated dramatically after 2001, driven by bioterrorism fears following the anthrax letter attacks, and again after the 2002 World Health Organization hand hygiene guidelines made alcohol-based sanitiser the recommended standard for healthcare workers. By 2020, before the COVID-19 pandemic, global hand sanitiser consumption had already grown tenfold from its 2001 baseline. The clinical rationale was unambiguous and correct: alcohol-based sanitisers reduce the transmission of pathogens that kill people, particularly in healthcare settings. The consequence that emerged alongside this benefit was documented in hospital infection data. Clostridioides difficile – a spore-forming bacterium that alcohol does not kill – saw increased prevalence in environments where alcohol-based protocols had displaced soap-and-water washing. More broadly, the skin microbiome – which alcohol disrupts more broadly than soap – was not part of the original risk calculation. It was not a consideration in 1988 or 2001. It is a consideration now.

Alcohol-based hand sanitizers entered widespread clinical use following a landmark randomized controlled trial by Pittet and colleagues at Geneva University Hospital, published in The Lancet in 2000. The trial showed that a hospital-wide hand hygiene program based on alcohol-based sanitizer substantially reduced healthcare-associated infection rates, including MRSA, over a three-year period. The results were striking – infection rates fell by approximately 40 percent – and drove global adoption of alcohol-based sanitizers in clinical settings. [267] The distinction between clinical and non-clinical use contexts is important for microbiota interpretation. In clinical settings – where the hands carry transient pathogens from patient contact and the primary goal is pathogen transmission prevention – alcohol sanitizers provide benefit that clearly outweighs any microbiota cost. In community settings – where the hands carry primarily commensal organisms and episodic contact with occasional pathogens – the cost-benefit calculation is different. [261] Several studies found that routine use of alcohol sanitizers in community settings, while reducing transient pathogen carriage, also reduced skin commensal populations including Staphylococcus epidermidis for the hours between applications. The skin recolonizes from protected sites within hours, so the effect on resident commensals is temporary. However, in individuals who sanitize very frequently in community settings – teachers, parents of young children, healthcare workers in non-clinical roles – the repeated disruption may maintain the skin in a lower-diversity state between applications. [257] The practical guidance is contextual: alcohol sanitizers are appropriate after contact with potentially contaminated surfaces or individuals, before food preparation, and in any situation where soap and water are unavailable. Routine use in settings where there is no identifiable infection transmission risk – desks, everyday objects, community environments – provides marginal benefit while sustaining a mild commensal suppression.

Alcohol-based hand sanitizers became routine tools in modern life, especially during outbreaks of infectious disease. From a medical perspective, their value is clear. They are among the most effective methods for reducing transmission of many pathogens, and international guidelines recommend their use in hospitals and other high-risk settings [261].

These preparations usually contain ethanol or isopropanol in concentrations between 60 and 95 percent. At this level they rapidly inactivate many bacteria and viruses. On healthy skin, however, the effect is temporary. Microorganisms return from hair follicles, deeper skin layers, clothing, and nearby surfaces. Hand sanitizers therefore reduce microbial load but do not permanently remove the resident skin microbiota.

The skin microbiota supports barrier function by helping maintain pH, producing antimicrobial peptides, and competing with pathogens. Repeated exposure to alcohol can dry the skin and disturb its lipid layer, particularly when combined with frequent washing or harsh detergents. In people with sensitive skin, eczema, or occupational exposure, this may lead to dermatitis, and inflammatory skin conditions themselves alter the local microbial community.

Studies in healthcare workers show that antiseptic treatments usually change skin microbial composition only for short periods. The main long-term concern is barrier irritation rather than lasting microbiota loss. Regular use of moisturizers and gentle cleansers helps maintain both skin integrity and microbial balance.

Patients often ask whether sanitizer use harms the gut microbiota. Direct clinical evidence for this is limited. Any influence would be indirect, through skin inflammation or immune signaling, and appears small compared with factors such as diet, antibiotics, or chronic illness.

In many situations alcohol-based sanitizers are safer for the skin than repeated handwashing with strong soaps. Soap removes microbes mechanically but also strips lipids if used frequently. Alternating between soap and sanitizer according to context, and restoring the skin barrier afterward, is usually the most practical strategy.

The clinical message is therefore balanced. Use alcohol-based sanitizers when infection risk is real, such as in hospitals, public transport, or during outbreaks. In everyday settings with access to water, gentle handwashing is often sufficient. Protecting the skin barrier supports both comfort and microbial stability.

Alcohol-based hand sanitizers are practical medical tools, not enemies of the microbiota. When used appropriately, they prevent infection without lasting harm to the skin ecosystem. Thoughtful hygiene—protecting against pathogens while caring for the skin barrier—remains the most evidence-based approach.

How Hand Sanitizers Fit into a Balanced Hygiene Routine

Alcohol-based hand sanitizers are best reserved for situations where infection risk is increased or when soap and water are not readily available, such as during travel, in public spaces, or in healthcare settings.

In everyday home environments, gentle handwashing with mild, non-antibacterial soap usually provides adequate hygiene while maintaining better skin barrier function.

Frequent sanitizer use on already dry or irritated skin often worsens barrier damage; products containing emollients such as glycerin tend to be better tolerated and help preserve microbial stability.

Alternating between handwashing and sanitizer use according to context allows effective infection control without unnecessary chemical exposure.

Children’s skin is more sensitive to irritants, so routine sanitizer use should be limited to situations where hygiene needs clearly justify it, while maintaining normal play and environmental contact.

Using several antimicrobial products simultaneously—sanitizers, antibacterial soaps, disinfectant wipes—can increase skin irritation without clear additional benefit in low-risk settings.

Supporting overall skin health with moisturizers and avoiding overly hot water helps maintain both barrier integrity and a stable skin microbial community.

Diet, antibiotic exposure, chronic illness, and stress remain far stronger influences on gut microbiota than hand sanitizer use; lifestyle balance therefore matters more than strict avoidance.

In clinical care, sanitizer use remains essential and safe; infection prevention must always take priority when risk is present.

Seen in this context, hand sanitizers function best as targeted medical tools within a broader, balanced hygiene strategy rather than as constant everyday substitutes for normal washing.

Microbiota Effects

• Alcohol-based hand sanitizers (ABHS) temporarily reduce microbial load on the skin, including common commensals such as Staphylococcus epidermidis, Cutibacterium acnes, and Corynebacterium species; recolonization typically occurs within hours from hair follicles and surrounding skin [257].
• Repeated ABHS use can impair the skin barrier mainly through lipid depletion, leading to dryness, irritation, increased transepidermal water loss (TEWL), and a higher risk of dermatitis; inflammatory skin disease itself alters local microbial composition.
• Current evidence suggests changes in skin microbiota after ABHS use are usually transient, not permanent loss of diversity, especially when skin integrity is maintained.
• In healthcare settings, ABHS use has not consistently been shown to increase colonization by opportunistic pathogens; dermatitis risk is more strongly linked to excessive washing with detergents than to ABHS alone.
• Altered skin barrier function may influence systemic immune signaling, but direct effects of ABHS on gut microbiota are not well demonstrated and appear small compared with antibiotics, diet, or illness.
• The skin microbiota interacts with immune cells through antimicrobial peptides, cytokine signaling, and T-cell modulation; barrier damage may therefore indirectly affect inflammatory tone.
• Children’s skin is more sensitive to irritants, so excessive cleansing can increase eczema risk, but routine sanitizer use in appropriate settings has not been shown to impair immune maturation.
• ABHS formulations containing emollients (e.g., glycerol) are associated with better skin tolerance and less barrier damage, which helps maintain stable microbial communities.
• Skin microbiota recovery occurs naturally; maintaining hydration, gentle cleansing, and avoiding unnecessary antimicrobial products supports this process.
• Overall, ABHS use should be understood as an infection-control tool with manageable, mostly short-term effects on the skin microbiota when used appropriately.

Patient Guidance

• Use alcohol-based sanitizer when infection risk is high or when soap and water are not available.
• Wash hands with mild, non-antibacterial soap for routine daily hygiene.
• Choose sanitizers with moisturizing ingredients to protect the skin barrier.
• Avoid repeated sanitizing when hands are not visibly dirty and risk is low.
• Moisturize hands regularly to prevent dryness and dermatitis.
• Do not combine sanitizer with antibacterial soaps or wipes unless medically needed.
• Use sanitizer in children only when necessary and supervise proper use.
• Seek medical advice if skin irritation, eczema, or cracks appear.
• Remember: infection prevention is essential, but constant sterilization is not required.

References

[24] Sonnenburg JL, Bäckhed F. Diet–microbiota interactions as moderators of human metabolism. Nature. 2016. Link

Review of mechanisms linking the gut microbiota to obesity and type 2 diabetes drawing on translational animal models and human studies. The microbiota emerges as a mediator of dietary impact on host metabolic status, with growing efforts to establish causal relationships in people and develop therapeutic interventions including personalised nutrition.

[257] Rook, G. A. Regulation of the immune system by biodiversity from the natural environment. Proc Natl Acad Sci USA. 2013. Link

This review summarizes evidence that proximity to natural environments associates with reduced mortality, cardiovascular disease and psychiatric morbidity. The authors highlight that rising chronic illness in high-income countries is associated with failing immunoregulation and persistent low-grade inflammation, partly attributable to lost exposure to evolutionarily co-adapted Old Friends microorganisms. The hypothesis links biodiversity-rich environments to immunoregulatory training that protects against chronic inflammatory disease. The findings reframe green-space exposure as immunological rather than purely psychological intervention.

[261] Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011. Link

This review describes the human skin microbiome's diversity and variability based on topography, host factors and environmental exposures. Cutaneous innate and adaptive immune responses modulate the skin microbiota, which in turn educates the immune system. Molecular characterization reveals highly diverse and dynamic skin bacterial communities. Understanding the skin microbiome is essential for advancing pro- and antimicrobial therapeutic strategies in dermatological disorders. The findings position the skin microbiome as both a target and effector in skin disease management.

[267] Pittet D, Hugonnet S, Harbarth S et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet. 2000. Link

Pittet and colleagues' 2000 Lancet study is the landmark before-after intervention trial of a hospital-wide hand-hygiene programme at the University of Geneva Hospitals. Over five years, the programme — based on alcohol-based hand rub at the point of care, education and feedback — improved compliance from 48% to 66%, halved methicillin-resistant Staphylococcus aureus (MRSA) transmission, and reduced overall nosocomial infections by 40%. The trial established alcohol-based hand rub as the cornerstone of healthcare-associated infection prevention and shaped WHO's Clean Care is Safer Care campaign. It remains the most cited reference for hand-hygiene implementation evidence.